documents: FDA-2022-N-2390-0132

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2390-0132 FDA FDA-2022-N-2390 Vanda Pharmaceuticals Inc.’s Submission in Support of Summary Judgment to the Applicant or a Hearing on Approvability of Tasimelteon to Treat Insomnia Associated with Difficulties with Sleep Initiation Other Brief 2025-03-04T05:00:00Z 2025 3 2025-03-04T05:00:00Z   2025-03-04T14:31:50Z   0 0 0900006486972393

Links from other tables